Helping Life Science and Healthcare Companies Achieve Growth Objectives

Growth Capital for Life Sciences and Healthcare

Telegraph Hill Partners, founded in 2001, is a venture capital firm dedicated to helping life science, medical device and healthcare companies achieve their growth objectives. When you work with us, you get an experienced team that knows how to efficiently drive growth and profitability while maintaining the vision and integrity of the organization.

"We seek to partner with innovative companies by providing capital and strategic guidance to help them become world-class businesses."

THP Focus & Strategy

We partner with private life science and healthcare companies that have novel technologies, a solid customer base, and innovative management teams. We make investments into high-quality companies looking for capital to help build and grow their organizations. We encourage you to contact us to learn more about Telegraph Hill Partners.

Read More

Latest News & Announcements

View All

Kytopen Expands Commercialization Efforts and Board of Directors Following Series B Investment Led by Telegraph Hill Partners

CAMBRIDGE, Mass. and SAN FRANCISCO, Calif., – April 07, 2026 – Kytopen Corp., a leader in non-viral, continuous flow cellular

PAI Pharma Acquires Nivagen Pharmaceuticals, Expanding Domestic Sterile Injectable Manufacturing and Ready-To-Use Product Offering in the Hospital Market

Greenville, SC and Sacramento, CA – PAI Pharma (“PAI”), a portfolio company of Olympus Partners and a leading U.S. developer,

FDA Clears Updated Magstim Rapid Transcranial Magnetic Stimulation Research System

Top-Cited TMS Brain Research Technology Enhanced for Next-Generation Neuromodulation MINNEAPOLIS, July 09, 2025 (GLOBE NEWSWIRE) The FDA has cleared the

This website uses cookies to enhance your browsing experience and ensure the site functions properly. By continuing to use this site, you acknowledge and accept our use of cookies.

Accept All Accept Required Only